180 related articles for article (PubMed ID: 17694434)
1. Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor.
Archer T; Fredriksson A
Neurochem Res; 2007 Oct; 32(10):1625-39. PubMed ID: 17694434
[TBL] [Abstract][Full Text] [Related]
2. Postnatal iron overload destroys NA-DA functional interactions.
Fredriksson A; Archer T
J Neural Transm (Vienna); 2007 Feb; 114(2):195-203. PubMed ID: 16932993
[TBL] [Abstract][Full Text] [Related]
3. Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice.
Fredriksson A; Eriksson P; Archer T
J Neural Transm (Vienna); 2006 Feb; 113(2):137-50. PubMed ID: 16082515
[TBL] [Abstract][Full Text] [Related]
4. Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration.
Fredriksson A; Archer T
Behav Brain Res; 2003 Feb; 139(1-2):31-46. PubMed ID: 12642174
[TBL] [Abstract][Full Text] [Related]
5. Influence of noradrenaline denervation on MPTP-induced deficits in mice.
Archer T; Fredriksson A
J Neural Transm (Vienna); 2006 Sep; 113(9):1119-29. PubMed ID: 16362627
[TBL] [Abstract][Full Text] [Related]
6. Neurobehavioural deficits following postnatal iron overload: I spontaneous motor activity.
Fredriksson A; Schröder N; Archer T
Neurotox Res; 2003; 5(1-2):53-76. PubMed ID: 14628856
[No Abstract] [Full Text] [Related]
7. Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration.
Fredriksson A; Archer T
Amino Acids; 2002; 23(1-3):111-32. PubMed ID: 12373526
[TBL] [Abstract][Full Text] [Related]
8. Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.
Fredriksson A; Archer T
Neurotox Res; 2006 Jun; 9(4):305-12. PubMed ID: 16782590
[TBL] [Abstract][Full Text] [Related]
9. Noradrenergic-Dopaminergic Interactions Due to DSP-4-MPTP Neurotoxin Treatments: Iron Connection.
Archer T
Curr Top Behav Neurosci; 2016; 29():73-86. PubMed ID: 26718588
[TBL] [Abstract][Full Text] [Related]
10. Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.
Fredriksson A; Archer T
Neurotox Res; 2006 Oct; 10(2):123-9. PubMed ID: 17062374
[TBL] [Abstract][Full Text] [Related]
11. Brain lipid composition in postnatal iron-induced motor behavior alterations following chronic neuroleptic administration in mice.
Isaac G; Fredriksson A; Danielsson R; Eriksson P; Bergquist J
FEBS J; 2006 May; 273(10):2232-43. PubMed ID: 16649999
[TBL] [Abstract][Full Text] [Related]
12. Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits.
Fredriksson A; Schröder N; Eriksson P; Izquierdo I; Archer T
Parkinsonism Relat Disord; 2001 Apr; 7(2):97-105. PubMed ID: 11248590
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
[TBL] [Abstract][Full Text] [Related]
14. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
Pugsley TA; Coughenour LL; Myers SL; Shih YH; Courtland GG; Berghoff W; Stewart SF
J Pharmacol Exp Ther; 1989 Oct; 251(1):113-22. PubMed ID: 2571713
[TBL] [Abstract][Full Text] [Related]
15. Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice.
St-Hilaire M; Bourhis E; Lévesque D; Rouillard C
Eur J Neurosci; 2006 Aug; 24(3):795-805. PubMed ID: 16930409
[TBL] [Abstract][Full Text] [Related]
16. Brain catecholamine concentration during the first week of development in rats.
Phelps CP; Korányi L; Tamásy V
Dev Neurosci; 1982; 5(5-6):503-7. PubMed ID: 7160315
[TBL] [Abstract][Full Text] [Related]
17. An antihypokinesic action of alpha2-adrenoceptors upon MPTP-induced behaviour deficits in mice.
Archer T; Fredriksson A
J Neural Transm (Vienna); 2003 Feb; 110(2):183-200. PubMed ID: 12589577
[TBL] [Abstract][Full Text] [Related]
18. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
19. Chronic haloperidol: neural correlates of motor disorders in an invertebrate model.
Sakharov D; Voronezhskaya E; Nezlin L
Neuroreport; 1994 Feb; 5(6):667-70. PubMed ID: 7911039
[TBL] [Abstract][Full Text] [Related]
20. Noradrenaline and dopamine interaction in rat brain during development.
Ponzio F; Hallman H; Jonsson G
Med Biol; 1981 Jun; 59(3):161-9. PubMed ID: 6796787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
